CLSA Initiates Coverage On Hutchison China Meditech with Buy Rating

CLSA initiates coverage on Hutchison China Meditech (NASDAQ:HCM) with a Buy rating.

Benzinga · 11/19/2019 15:52

CLSA initiates coverage on Hutchison China Meditech (NASDAQ:HCM) with a Buy rating.